default author photo

Barbara Seitz-Polski

Nice University Hospital - Department of Immunology

Nice, 06200

France

SCHOLARLY PAPERS

2

DOWNLOADS

812

TOTAL CITATIONS

3

Scholarly Papers (2)

1.

Safety and Cross-Variant Immunogenicity of a Three-Dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients

Number of pages: 27 Posted: 22 Jul 2021
Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Clinical Research Unit Côte d’Azur, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Department of Immunology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, University Côte d’Azur, CNRS - Laboratory of Molecular Physio Medicine, University Côte d’Azur, CNRS - Institute of Molecular and Cellular Pharmacology, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Nice University Hospital - Laboratory of Clinical and Experimental Pathology, Nice University Hospital - Department of Immunology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Nice University Hospital - Laboratory of Clinical and Experimental Pathology, Nice University Hospital - Department of Nephrology, Dialysis and Transplantation, Université Côte d'Azur - Institute of Molecular and Cellular Pharmacology, Nice University Hospital - Department of Immunology, University Côte d’Azur, CNRS - Institute of Molecular and Cellular Pharmacology and Nice University Hospital - Department of Nephrology, Dialysis and Transplantation
Downloads 592 (113,998)
Citation 2

Abstract:

Loading...

2.

Chilblains Appear as a Manifestation of SARS-CoV-2 Infection and Reveal Features of Type I Interferonopathy and Micro-Vasculopathy

Number of pages: 58 Posted: 01 Jun 2020
Université Cote d'Azur - Service de Dermatologie, Université Cote d'Azur - Centre Hospitalier Universitaire de Nice, Université Cote d'Azur - Centre Hospitalier Universitaire de Nice, Centre Hospitalier Universitaire de Nice - Department of Vascular Medicine, Université Cote d'Azur - Service de Dermatologie, Nice University Hospital - Department of Immunology, Centre Hospitalier Universitaire de Nice - Department of Virology, Centre Hospitalier Universitaire de Nice - Department of Virology, Cerballiance Côte d’Azur, Cerballiance Côte d’Azur, Cerballiance Côte d’Azur, Université Cote d'Azur - Service de Dermatologie, Centre Hospitalier Universitaire de Nice - Department of Pathology, Centre Hospitalier Universitaire de Nice - Department of Pathology, Centre Hospitalier Universitaire de Nice - Department of Vascular Medicine, Université Cote d'Azur - Service de Dermatologie, Centre Hospitalier Universitaire de Nice - Department of Infectiology, Centre Hospitalier Universitaire de Nice - Department of Infectiology, Centre Hospitalier Universitaire de Nice - Emergency Department, Centre Hospitalier Universitaire de Nice - Medical Intensive Care Unit, Centre Hospitalier Universitaire de Nice - Department of Vascular Medicine and Université Cote d'Azur - Service de Dermatologie
Downloads 220 (348,255)
Citation 1

Abstract:

Loading...

COVID-19; SARS-CoV-2; Chilblains; Type I interferonopathy; Micro-vasculopathy; Pericytes